These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 8899700)
1. Muscarinic receptors in Alzheimer's disease. Pavía J; de Ceballos ML; Sánchez de la Cuesta F Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():71-5. PubMed ID: 8899700 [No Abstract] [Full Text] [Related]
2. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters. Muma NA; Mariyappa R; Williams K; Lee JM Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374 [TBL] [Abstract][Full Text] [Related]
3. Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease. Shiozaki K; Iseki E J Neurol Sci; 2004 Aug; 223(2):145-8. PubMed ID: 15337615 [TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: A needle from the haystack. Morris R; Mucke L Nature; 2006 Mar; 440(7082):284-5. PubMed ID: 16541054 [No Abstract] [Full Text] [Related]
5. The immune system, amyloid-beta peptide, and Alzheimer's disease. Weksler ME; Gouras G; Relkin NR; Szabo P Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358 [TBL] [Abstract][Full Text] [Related]
6. Intracellular amyloid-beta in Alzheimer's disease. LaFerla FM; Green KN; Oddo S Nat Rev Neurosci; 2007 Jul; 8(7):499-509. PubMed ID: 17551515 [TBL] [Abstract][Full Text] [Related]
7. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease. Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173 [TBL] [Abstract][Full Text] [Related]
8. Effects of central galanin administration on muscarinic cholinergic and galanin receptor G protein coupling. Barreda-Gómez G; Giralt MT; Rodríguez-Puertas R Neuropeptides; 2005 Jun; 39(3):157-60. PubMed ID: 15944005 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease. A partner for presenilin. Schenk D Nature; 2000 Sep; 407(6800):34-5. PubMed ID: 10993060 [No Abstract] [Full Text] [Related]
10. Alzheimer's disease: relationship between muscarinic cholinergic receptors, beta-amyloid and tau proteins. Pavía J; de Ceballos ML; Sanchez de la Cuesta F Fundam Clin Pharmacol; 1998; 12(5):473-81. PubMed ID: 9794144 [TBL] [Abstract][Full Text] [Related]
11. Cholesterol homeostasis and the pathophysiology of Alzheimer's disease. Blain JF; Poirier J Expert Rev Neurother; 2004 Sep; 4(5):823-9. PubMed ID: 15853509 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal. Sayre LM; Zagorski MG; Surewicz WK; Krafft GA; Perry G Chem Res Toxicol; 1997 May; 10(5):518-26. PubMed ID: 9168248 [No Abstract] [Full Text] [Related]
13. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation. Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234 [TBL] [Abstract][Full Text] [Related]
14. Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Tanzi RE; Moir RD; Wagner SL Neuron; 2004 Sep; 43(5):605-8. PubMed ID: 15339642 [TBL] [Abstract][Full Text] [Related]
15. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Klunk WE; Mathis CA; Price JC; Lopresti BJ; DeKosky ST Brain; 2006 Nov; 129(Pt 11):2805-7. PubMed ID: 17071918 [No Abstract] [Full Text] [Related]